DGS Capital Management LLC grew its stake in shares of InMode Ltd. (NASDAQ:INMD – Free Report) by 127.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 79,613 shares of the healthcare company’s stock after acquiring an additional 44,654 shares during the quarter. DGS Capital Management LLC owned about 0.13% of InMode worth $1,170,000 as of its most recent SEC filing.
Other hedge funds also recently bought and sold shares of the company. Leonteq Securities AG bought a new stake in InMode during the 4th quarter valued at about $26,000. Quadrant Capital Group LLC raised its holdings in InMode by 127.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,945 shares of the healthcare company’s stock worth $29,000 after buying an additional 1,091 shares during the last quarter. Advisory Services Network LLC bought a new position in shares of InMode in the third quarter worth approximately $37,000. Basepoint Wealth LLC bought a new position in shares of InMode in the fourth quarter worth approximately $39,000. Finally, Deutsche Bank AG grew its holdings in shares of InMode by 35.9% during the fourth quarter. Deutsche Bank AG now owns 3,927 shares of the healthcare company’s stock valued at $58,000 after buying an additional 1,037 shares during the last quarter. Institutional investors own 68.04% of the company’s stock.
Wall Street Analyst Weigh In
INMD has been the subject of several analyst reports. Barclays set a $19.00 price target on shares of InMode and gave the company an “overweight” rating in a research report on Thursday, May 7th. Robert W. Baird decreased their price target on InMode from $17.00 to $14.00 and set a “neutral” rating for the company in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $16.00.
InMode Trading Up 0.3%
NASDAQ:INMD opened at $13.40 on Friday. The company has a market cap of $849.02 million, a PE ratio of 9.85 and a beta of 1.94. The company has a 50 day simple moving average of $13.90 and a two-hundred day simple moving average of $14.15. InMode Ltd. has a 12 month low of $12.72 and a 12 month high of $16.74.
InMode (NASDAQ:INMD – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The healthcare company reported $0.25 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.05). The firm had revenue of $82.02 million during the quarter, compared to analysts’ expectations of $79.84 million. InMode had a return on equity of 13.47% and a net margin of 23.27%.The business’s quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the business earned $0.31 earnings per share.
InMode Company Profile
InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.
InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.
The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.
Featured Articles
- Five stocks we like better than InMode
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.
